Clinical characteristics of Japanese patients with moderate to severe COVID-19

INTRODUCTION: Although several reports on the risk factors for severe disease of COVID-19 already exist, reports on effective early indicators are still limited, especially from Japan. This study was conducted to clarify the patient’s characteristics whose disease progressed to severe status. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Otoshi, Ryota, Hagiwara, Eri, Kitayama, Takaaki, Yamaya, Takafumi, Higa, Katsuyuki, Murohashi, Kota, Sato, Yozo, Tabata, Erina, Shintani, Ryota, Okabayashi, Hiroko, Ikeda, Satoshi, Niwa, Takashi, Nakazawa, Atsuhito, Oda, Tsuneyuki, Okuda, Ryo, Sekine, Akiamasa, Kitamura, Hideya, Baba, Tomohisa, Komatsu, Shigeru, Ogura, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931728/
https://www.ncbi.nlm.nih.gov/pubmed/33727024
http://dx.doi.org/10.1016/j.jiac.2021.02.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931728/
https://www.ncbi.nlm.nih.gov/pubmed/33727024
http://dx.doi.org/10.1016/j.jiac.2021.02.028

Ejemplares similares